Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Revenue $ 13,037 $ 16,574
Cost of revenue 7,102 9,807
Gross profit 5,935 6,767
Operating expenses    
Research and development 1,432 2,276
Sales and marketing 2,137 2,336
General and administrative 1,534 1,711
Intangible amortization 990 1,047
Total operating expenses 6,093 7,370
Operating profit (loss) (158) (603)
Other income, net 119 43
Income (loss) before income taxes (39) (560)
Income tax benefit (expense) 0 (12)
Net income (loss) $ (39) $ (572)
Net income (loss) per share:    
Basic $ 0.00 $ (0.04)
Diluted $ 0.00 $ (0.04)
Weighted-average number of common shares outstanding:    
Basic (shares) 15,632 15,481
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options (1) [1] 0 0
Diluted (shares) 15,632 15,481
Product [Member]    
Revenue $ 11,789 $ 14,784
Service [Member]    
Revenue $ 832 $ 1,029
[1] The Company had 1.0 million and 1.1 million shares represented by common stock equivalents for the three months ended June 30, 2018, and June 30, 2017, respectively, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation.